Mackenzie Financial Corp Eli Lilly & CO Transaction History
Mackenzie Financial Corp
- $71.6 Billion
- Q2 2025
A detailed history of Mackenzie Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Mackenzie Financial Corp holds 223,873 shares of LLY stock, worth $185 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
223,873
              Previous 252,434
              
        
           11.31%
        
      
          
        Holding current value
$185 Million
            Previous $208 Million
            
        
           16.29%
        
      
          
        % of portfolio
0.24%
            Previous 0.32%
          
        Shares
	  31 transactions
	
  Others Institutions Holding LLY
# of Institutions
4,467Shares Held
781MCall Options Held
16.5MPut Options Held
12.3M- 
    
      Lilly Endowment Inc Indianapolis, IN96MShares$79.3 Billion0.0% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA80.4MShares$66.4 Billion1.05% of portfolio
- 
    
      Black Rock Inc. New York, NY65.9MShares$54.4 Billion1.37% of portfolio
- 
    
      Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$42.4 Billion26.07% of portfolio
- 
    
      State Street Corp Boston, MA34.5MShares$28.5 Billion1.04% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $785B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...